MedTech Innovator Asia Pacific
MedTech Innovator Asia Pacific is a Singapore-based non-profit accelerator that runs the region's largest medical-technology accelerator, supporting early- to mid-stage medical device, diagnostic, and digital health startups with mentorship, curriculum, pitch events, and up to USD 300,000 in non-dilutive cash prizes, funded by corporate sponsors and partner organizations.
- Company typePrivate
- Founded2019
- HeadquartersSingapore, Singapore
- Headcount1–10
- GTM typeB2B
- OfferingServices
What MedTech Innovator Asia Pacific does
MedTech Innovator Asia Pacific (MedTech Innovator APAC) is a Singapore-based non-profit accelerator, established in 2019 as the regional affiliate of the U.S. parent MedTech Innovator (operating since 2013). It runs the region's largest medical-technology accelerator program, supporting early- to mid-stage startups across medical devices, diagnostics, and digital health that are headquartered in or have strategic interest in the Asia Pacific region.
The core product is a four-month accelerator cohort fed by a structured Pitch Events RoadTour (virtual pitch events plus in-person MedTech Spotlight events in Korea and Singapore). Selected startups receive mentorship from 100+ judges and mentors, a curriculum spanning fundraising, regulatory, IP, clinical, and commercial topics, exposure to investors and strategics, and the chance to compete for up to USD 300,000 in non-dilutive cash prizes and ancillary awards (Cambridge Consultants Product Development Prize, Enterprise Singapore Startup SG Grant). Complementary offerings include the U.S. Market Access Program for Singapore-based companies seeking U.S. entry, plus a webinar series and an annual Showcase & Grand Finals event held in Singapore. The platform architecture is community- and event-driven: it operates as an application portal plus a recurring in-person/virtual event franchise rather than as a software product.
The business model is sponsorship-funded rather than equity- or fee-based: MedTech Innovator APAC does not take equity from startups and charges no application fee. Revenue mechanics consist of multi-year corporate sponsorship agreements with medtech manufacturers and ecosystem partners — Johnson & Johnson MedTech as the flagship Acceleration Partner, with B. Braun, Siemens Healthineers, Enterprise Singapore, KHIDI, KMDIA, Blue Goat Cyber, Dovetail, Cambridge Consultants, The Mullings Group, APACMed, and BLOCK71 among the named Innovation, Preferred, and Growth partners. Operating geographies span Southeast Asia, East Asia, South Asia, and Oceania, with linkages into North America and Europe via the parent organization and the U.S. Market Access Program. Headcount is approximately six, organized around a Managing Director, Senior Program Director, Program Manager, Partnerships Manager, and Marketing & Events Manager, all based in Singapore.
MedTech Innovator Asia Pacific firmographics
Firmographics- Name
- MedTech Innovator Asia Pacific
- Legal name
- MedTech Innovator Asia Pacific Pte Ltd
- Website
- https://medtechinnovator.asia
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MedTech Innovator Asia Pacific is a Singapore-based non-profit accelerator that runs the region's largest medical-technology accelerator, supporting early- to mid-stage medical device, diagnostic, and digital health startups with mentorship, curriculum, pitch events, and up to USD 300,000 in non-dilutive cash prizes, funded by corporate sponsors and partner organizations.
- Ownership category
- akta.pro rank
Where MedTech Innovator Asia Pacific is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices1 record
Markets served
MedTech Innovator Asia Pacific business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Non-dilutive accelerator program: MedTech Innovator APAC does not take equity from participating startups and does not charge an application fee. The program is funded through sponsorship and partnership agreements with corporate partners (e.g., Johnson & Johnson MedTech as Acceleration Partner, B. Braun, Siemens Healthineers, Enterprise Singapore, KHIDI as Innovation Partners) who gain access to the innovation ecosystem and startup pipeline.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | No fee for participation — no equity taken, no application fee charged |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels10 records
MedTech Innovator Asia Pacific product offering
Product offeringCore offering
MedTech Innovator Asia Pacific runs a non-equity, no-application-fee accelerator for early-to-mid-stage medical device, digital health, and diagnostics startups across the Asia-Pacific region. The flagship offering is the APAC Accelerator Program, which combines mentorship, industry networking, and pitch competitions awarding up to USD 300,000 in cash prizes, supported by a U.S. Market Access Program, regional Pitch Events and RoadTour, MedTech Spotlight showcases, and a recurring webinar series.
Product overview
MedTech Innovator Asia Pacific is an accelerator program operated by MedTech Innovator Asia Pacific Pte Ltd, based in Singapore, that connects medical technology startups with industry leaders, investors, and ecosystem partners across the Asia Pacific region. The core offerings include the APAC Accelerator Program, a four-month intensive program providing mentorship, educational curriculum, and pitch opportunities; the U.S. Market Access Program, supporting Singapore-based companies in entering the U.S. market; and Pitch Events RoadTour featuring MedTech Spotlight events in Korea and Singapore. The program awards up to USD 300,000 in cash prizes and provides access to Pitchbook, webinars, and a network of mentors and judges from leading healthcare organizations.
Differentiator
Problem solved
Functional benefit
Products and services
- APAC Accelerator Program
Quantifiable outcome
- Over 200 alumni startups supported across multiple cohorts
- +3 more outcomes
Companies that use MedTech Innovator Asia Pacific
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles2 records
MedTech Innovator Asia Pacific technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MedTech Innovator Asia Pacific partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered flagship, core and minor.
- Johnson & Johnson MedTechflagshipJohnson & Johnson MedTech serves as the Acceleration Partner — the highest-tier partner level. As a founding sponsor both globally and in the region, J&J MedTech contributes industry expertise, resources, and connections to help innovators overcome barriers and bring life-changing technologies to patients faster. They actively engage with the startup pipeline through mentorship, judging, and corporate presentation sessions.
- B. BrauncoreB. Braun is an Innovation Partner providing strategic mentorship, judging at pitch events, and engagement with cohort startups. B. Braun contributes R&D expertise and innovation research capabilities to the program ecosystem.
- Siemens HealthineerscoreSiemens Healthineers serves as an Innovation Partner, contributing strategy, regulatory, and market access expertise. Representatives participate as judges and mentors across program events and pitch sessions.
- Enterprise SingaporecoreEnterprise Singapore is an Innovation Partner supporting Singapore-based medtech startups through the program. They offer the Startup SG Grant Award to qualifying cohort companies and provide access to Singapore's broader innovation ecosystem.
- Korea Health Industry Development Institute (KHIDI)coreKHIDI is a government agency advancing Korea's bio-health industry by supporting innovation, global expansion, and connections across research, industry, and markets. They collaborate with MTI APAC to launch MedTech Spotlight: New Impact Korea 2026, bringing Korean innovators together with global strategics, international investors, and hospital leaders.
- Korea Medical Devices Industry Association (KMDIA)coreKMDIA is the leading organization and collective voice of medical device manufacturers, importers, and innovators in South Korea. They support the MedTech Spotlight: New Impact Korea 2026 event in conjunction with KIMES 2026, providing access to the Korean medtech ecosystem.
- Blue Goat CybercoreBlue Goat Cyber is an Innovation Partner bringing cybersecurity expertise to the program, particularly relevant for digital health and connected medical device startups seeking to strengthen their security posture.
- DovetailcoreDovetail serves as a Growth Partner, providing regulatory and quality advisory services to cohort companies. Dovetail's Head of Regulatory and Quality leads webinar sessions on APAC vs U.S. regulatory strategy.
- Cambridge ConsultantscoreCambridge Consultants is a Preferred Partner providing product development expertise and mentoring more than 30 companies through the MTI program. They award the annual Cambridge Consultants Product Development Prize to a standout cohort company.
- The Mullings GroupcoreThe Mullings Group is a Preferred Partner contributing senior leadership expertise to the judging panel and mentorship program. Ajay Nair leads the international business for TMG and participates as a key judge and mentor across pitch events.
- BLOCK71 Singapore (NUS Enterprise)coreBLOCK71 Singapore, part of NUS Enterprise's global network of innovation hubs across 11 cities in 6 countries, co-organizes the flagship MedTech Spotlight: Singapore event. They provide access to the broader startup ecosystem and innovation infrastructure.
- Asia Pacific Medical Technology Association (APACMed)coreAPACMed is the region's first and only MedTech industry association. Gabriel Sim, Director of Strategic Partnerships at APACMed, participates as a judge and mentor in the program.
- KIMEScoreKIMES 2026 is a major Korean medical equipment exhibition held at COEX in Seoul. MedTech Spotlight: New Impact Korea 2026 is held in conjunction with KIMES 2026, providing participating startups with visibility at a major regional trade show.
- Singapore Week of Innovation and Technology (SWITCH)minorGlen Lim, Senior Program Director at MTI APAC, previously led programs at SWITCH. MTI APAC alumni such as Qritive have been featured at SWITCH's Slingshot competition, creating cross-program visibility.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
MedTech Innovator Asia Pacific competitors and assessment
Company assessmentDirect peers
- IndieBio: Biotech accelerator program with cohorts in San Francisco and New York. Comparable in supporting early-stage life science and health startups with mentorship, investor exposure, and demo days, though takes equity unlike MTI APAC.
- MedTech Innovator (US): The U.S. parent program operating since 2013, described as the world's largest MedTech accelerator. Same methodology, curriculum, and brand; the most directly comparable peer for cohort companies and sponsors.
- Startupbootcamp Digital Health: Digital health-focused accelerator running cohort programs globally, including in APAC. Directly comparable in serving early-stage digital health and medtech startups with mentorship, partner access, and demo days.
- SPARK Global: Stanford-origin translational medicine accelerator network with sites worldwide, including Asia. Comparable as an academic-affiliated medtech accelerator providing mentorship and milestones-based support to early-stage medical device and digital health startups.
- Techstars Healthcare: Techstars' healthcare-focused accelerator partnerships with major providers and payers (e.g., Cedars-Sinai, UnitedHealthcare). Directly comparable in providing cohort-based mentorship and strategic partner introductions to health and medtech startups.
Regional players
- Biolabs (Biolabs Global): International network of co-working and accelerator spaces for life science startups. Comparable in supporting early-stage biotech and medtech founders with infrastructure and ecosystem connections, though more infrastructure-led than cohort-driven.
- BLOCK71 Singapore (NUS Enterprise): Singapore-based global innovation hub network of NUS Enterprise across 11 cities. Co-organizes MedTech Spotlight: Singapore with MTI APAC, so directly comparable in nurturing APAC medtech founders, though broader in sector scope.
Broad incumbents
- Plug and Play Health: Global innovation platform with a dedicated Health vertical that runs accelerator cohorts and connects startups with corporate partners. Comparable in serving medtech/digital health founders through cohort-based programs and corporate sponsorship.
- Y Combinator: Generalist but massive global accelerator that includes digital health and biotech startups in its cohorts. Comparable as an early-stage accelerator serving medtech founders, but with a broader scope and equity-based model.
- Johnson & Johnson Innovation – JLABS: J&J's flagship no-strings-attached life science incubator network. Highly relevant because J&J MedTech is MTI APAC's flagship partner, and JLABS targets overlapping medical device and digital health startups with residency-style accelerator models.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
MedTech Innovator Asia Pacific social profiles
Digital presenceMedTech Innovator Asia Pacific financial estimates
Financial estimateRevenue estimate
Valuation estimate
MedTech Innovator Asia Pacific leadership team
Management profileNumber of profiles
Profiles5 records
MedTech Innovator Asia Pacific funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MedTech Innovator Asia Pacific M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MedTech Innovator Asia Pacific
What does MedTech Innovator Asia Pacific do?
MedTech Innovator Asia Pacific runs a non-equity, no-application-fee accelerator for early-to-mid-stage medical device, digital health, and diagnostics startups across the Asia-Pacific region. The flagship offering is the APAC Accelerator Program, which combines mentorship, industry networking, and pitch competitions awarding up to USD 300,000 in cash prizes, supported by a U.S. Market Access Program, regional Pitch Events and RoadTour, MedTech Spotlight showcases, and a recurring webinar series.
Is MedTech Innovator Asia Pacific a public or private company?
MedTech Innovator Asia Pacific is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was MedTech Innovator Asia Pacific founded?
MedTech Innovator Asia Pacific was founded in 2019. It employs 1 to 10 people.
Where is MedTech Innovator Asia Pacific based?
MedTech Innovator Asia Pacific is headquartered in Singapore, Singapore, in the Asia region.
How does MedTech Innovator Asia Pacific make money?
One revenue line is on record: non-dilutive accelerator program.
Who are MedTech Innovator Asia Pacific's main competitors?
Direct peers on record are IndieBio, MedTech Innovator (US), Startupbootcamp Digital Health, SPARK Global and Techstars Healthcare. Regional players are Biolabs (Biolabs Global) and BLOCK71 Singapore (NUS Enterprise). Broad incumbents are Plug and Play Health, Y Combinator and Johnson & Johnson Innovation – JLABS.
Does MedTech Innovator Asia Pacific have an API?
No public API is recorded for MedTech Innovator Asia Pacific.